Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

sanofi-aventis transfers Exubera rights to Pfizer

Jan. 20, 2006

ChemGenex and Merck KGaA sign new three-year alliance agreement

Jan. 20, 2006

Technosphere Insulin produces improved glycemic control

Jan. 19, 2006

FDA extends Myozyme review period

Jan. 19, 2006

Adverse event analysis raises questions about mifepristone

Jan. 19, 2006

Oral contraceptives may lead to sex hormone-binding globulin elevation

Jan. 18, 2006

FDA approves CIP-Fenofibrate

Jan. 18, 2006

Vitor shows therapeutic effect in cancer cachexia

Jan. 17, 2006

SB-509 set for phase II trial in diabetic neuropathy in H2 2006

Jan. 17, 2006

Novel orally active CB1 receptor inverse agonist decreases food intake in rodents

Jan. 16, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 19, 2026.
ASGCT 2026: Directed evolution in gene therapy
BioWorld
Directed evolution has become a central pillar in gene therapy. This engineering strategy enables the generation of more efficient variants of genetic editors and...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
Authorities work to quickly sequence Ebola species in latest outbreak
BioWorld
If the recent hantavirus outbreak wasn’t enough to keep public health officials busy, a new Ebola virus disease outbreak has been confirmed by authorities in the...
Camp4 studies CMP-002 in SYNGAP1 haploinsufficient mouse model
BioWorld Science
Camp4 Therapeutics Corp. has highlighted new preclinical data for CMP-002, the company’s lead investigational antisense oligonucleotide (ASO) therapeutic...